An accepted view is that metformin exerts anti-tumor effects through various proposed mechanisms, including the modulation of the cellular AMP/ATP ratio, activation of the AMPK/mTOR pathway, inhibition of mitochondrial complex I, and suppression of gluconeogenesis [15,16]. This evidence concerns the gene MTOR and neoplasm.